Is a new sleep apnea drug a possible solution for OSA sufferers? The possibility does exist. Galleon Pharmaceuticals, Inc., is attempting to fund further research of an oral sleep apnea drug that could change the lives and lifestyles of millions of OSA sufferers around the world. However, the drug is not yet proven to work, and research and development could take many, many years.
James C. Mannion, the founder and CEO of the 9-year-old Horsham biopharmaceutical company, illustrated Galleon’s value proposition by holding a CPAP (continues positive airway pressure) mask in one hand and a small pill in his other hand and asks, “Which would you rather use?”
Galleon is in the process of raising $20 million to support clinical testing of its two lead products: GAL-160, the oral medicine for sleep apnea and GAL-021, an intravenous drug being developed to treat respiratory complications in hospitalized patients receiving anesthetics and opioids for pain relief.
Unfortunately, clinical studies can take years or even decades. In addition, there is no guarantee that tests will reflect positive results and an effective product. Even if a successful solution is found, bringing a sleep apnea drug to market is still far out in the future. Meanwhile, you are tired. Of, and because of, your sleep apnea.
Sleep Apnea Surgery: A Permanent Solution, Available Now
Surgical Sleep Solutions offers an immediately available, permanent solution to your obstructive sleep apnea issue. Although it's not a magic pill, it is a proven solution for your sleep disorder that doesn't involve nightly treatments or a loud machine.
Read more about Maxillo-Mandibular Advancement, and how it can provide you with a good night's sleep. To learn more about whether you may be a good candidate for sleep apnea surgery, contact us today.